USPTO serial 90731919
SMARTVITAL+
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SALES, HEATHER ALISON
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SMARTVITAL+?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical apparatus and instruments for monitoring vital signs, heart abnormalities and arrhythmias, blood pressure, heart rate, pulse, blood oxygen saturation, temperature, skin temperature, body weight and cardiac output; Medical apparatus and instruments for monitoring vital signs that result in emergent health events and alerts while the patient is sleeping, namely, vital signs, heart abnormalities and arrhythmias, blood pressure, heart rate, pulse, blood oxygen saturation, temperature, skin temperature, cardiac output for nightly patient monitoring; Medical apparatus and instruments for monitoring vital signs to detect sleep apnea while the patient is sleeping, namely, vital signs, heart abnormalities and arrhythmias, blood pressure, heart rate, pulse, blood oxygen saturation, temperature, skin temperature, excessive movement, restlessness, respiratory rate and cardiac output; Medical apparatus and instruments for monitoring patients vital signs aging at home, patients' vital signs who need home assistance, patients' vital signs recovering from postoperative surgery, patients' vital signs undergoing preoperative approval for surgery, patients' vital signs in a contaminated environment, patients' vital signs who are quarantined, patients' vital signs with acute undefined illness; Medical apparatus and instruments for monitoring vital signs, heart abnormalities and arrhythmias, blood pressure, heart rate, pulse, blood oxygen saturation, temperature, skin temperature, body weight and cardiac output for a patient who is attending a virtual telemedicine visit; Medical apparatus and instruments for monitoring health, namely, vital signs, heart abnormalities and arrhythmias, blood pressure, heart rate, pulse, blood oxygen saturation, temperature, skin temperature, body weight and cardiac output; Medical apparatus and instruments for treating cardiovascular disease; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, respiratory events, and vital signs, and also featuring a system consisting of a central processing unit, computer memory, local area network hardware, wireless speakers, wireless routers, data storage, data transfer, remote monitoring, machined learning models, deep learning neural networks and led screens for transmitting monitored data through the Internet, as a component of the medical devices; Medical devices for treating sleep disorders; Medical devices for use in treating or diagnosing coronavirus, flu, colds, cardiac arrhythmias, atrial fibrillation, ventricular fibrillation, p waves, hypertension, sepsis, fever, sleep apnea, sleeping disorders, pneumonia and respiratory illnesses; Medical devices, namely, pulse oximeters | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 30, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 30, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 26, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 15, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 15, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 25, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 28, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 18, 2023 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Apr 1, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 1, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 1, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 7, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 7, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 4, 2023 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Feb 4, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Feb 4, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Feb 4, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 18, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 18, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 18, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 18, 2023 | ALIE | ASSIGNED TO LIE | — |
| Nov 17, 2022 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Nov 17, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 17, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 17, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 14, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 14, 2022 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Oct 14, 2022 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Apr 13, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 13, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 13, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 13, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 13, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 13, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 13, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 6, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 6, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 6, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 5, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 19, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 27, 2021 | NWAP | NEW APPLICATION ENTERED | — |